Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Marcus Bitter

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|May 16, 2012
PROLIX: rapid mining of protein-ligand interactions in large crystal structure databasesMartin Weisel, Hans-Marcus Bitter, François Diederich, et al.
Biostatistics (Oxford, England)|February 24, 2009
A simulation-approximation approach to sample size planning for high-dimensional classification studiesPerry de Valpine, Hans-Marcus Bitter, Michael P S Brown, et al.
Molecular Informatics|July 28, 2016
Missing Value Estimation for Compound-Target Activity DataYusuf Tanrikulu, Rama Kondru, Gisbert Schneider, et al.
Molecular Immunology|January 30, 2013
Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functionsGang Chen, Sandip Panicker, Kai-Yeung Lau, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|May 16, 2012
PROLIX: rapid mining of protein-ligand interactions in large crystal structure databasesMartin Weisel, Hans-Marcus Bitter, François Diederich, et al.
Biostatistics (Oxford, England)|February 24, 2009
A simulation-approximation approach to sample size planning for high-dimensional classification studiesPerry de Valpine, Hans-Marcus Bitter, Michael P S Brown, et al.
Molecular Informatics|July 28, 2016
Missing Value Estimation for Compound-Target Activity DataYusuf Tanrikulu, Rama Kondru, Gisbert Schneider, et al.
Molecular Immunology|January 30, 2013
Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functionsGang Chen, Sandip Panicker, Kai-Yeung Lau, et al.
Pageof 1